Theratechnologies Inc.
NASDAQ:THTX
2.62 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 85.866 | 81.764 | 80.057 | 69.823 | 66.053 | 63.216 | 44.055 | 33.225 | 27.604 | 22.55 | 5.9 | 7.131 | 13.657 |
| Cost of Revenue
| 20.448 | 19.635 | 26.279 | 23.26 | 26.902 | 26.076 | 14.679 | 17.153 | 10.136 | 6.699 | 7.074 | 10.463 | 11.473 |
| Gross Profit
| 65.418 | 62.129 | 53.778 | 46.563 | 39.151 | 37.14 | 29.376 | 16.072 | 17.468 | 15.85 | -1.174 | -3.332 | 2.184 |
| Gross Profit Ratio
| 0.762 | 0.76 | 0.672 | 0.667 | 0.593 | 0.588 | 0.667 | 0.484 | 0.633 | 0.703 | -0.199 | -0.467 | 0.16 |
| Reseach & Development Expenses
| 16.878 | 30.37 | 36.939 | 28.274 | 18.019 | 10.841 | 7.768 | 9.19 | 5.655 | 4.109 | 4.946 | 7.093 | 7.08 |
| General & Administrative Expenses
| 14.852 | 15.617 | 17.356 | 14.616 | 12.23 | 8.33 | 5.828 | 4.508 | 3.565 | 2.993 | 4.002 | 3.549 | 5.498 |
| Selling & Marketing Expenses
| 25.419 | 26.769 | 39.391 | 28.909 | 26.859 | 26.482 | 21.693 | 20.166 | 10.865 | 9.662 | 6.102 | 0.236 | 0.858 |
| SG&A
| 40.271 | 42.386 | 56.747 | 43.525 | 39.089 | 34.812 | 25.02 | 24.675 | 14.536 | 12.741 | 10.104 | 3.838 | 6.356 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.85 | 22.072 |
| Operating Expenses
| 57.244 | 72.756 | 93.686 | 71.799 | 57.108 | 45.653 | 32.788 | -30.635 | -16.764 | -14.276 | -8.21 | -0.902 | -16.974 |
| Operating Income
| 8.174 | -10.627 | -39.908 | -25.236 | -17.957 | -8.513 | -3.412 | -8.602 | 2.932 | 3.11 | -7.676 | -7.17 | -4.172 |
| Operating Income Ratio
| 0.095 | -0.13 | -0.498 | -0.361 | -0.272 | -0.135 | -0.077 | -0.259 | 0.106 | 0.138 | -1.301 | -1.005 | -0.305 |
| Total Other Income Expenses Net
| -14.475 | -12.909 | -6.886 | -6.426 | -4.694 | -3.983 | -2.557 | -5.719 | -2.151 | -1.504 | -1.535 | 3.366 | -9.856 |
| Income Before Tax
| -6.301 | -23.536 | -46.794 | -31.662 | -22.651 | -12.496 | -5.775 | -14.301 | 0.781 | 1.606 | -9.211 | -3.804 | -14.028 |
| Income Before Tax Ratio
| -0.073 | -0.288 | -0.585 | -0.453 | -0.343 | -0.198 | -0.131 | -0.43 | 0.028 | 0.071 | -1.561 | -0.533 | -1.027 |
| Income Tax Expense
| 2.005 | 0.421 | 0.443 | 0.063 | 0.016 | 4.99 | -1.25 | -0.002 | 0.476 | 0.427 | 0.027 | 0.025 | 0.005 |
| Net Income
| -8.306 | -23.957 | -47.237 | -31.725 | -22.667 | -12.496 | -4.524 | -14.301 | 0.305 | 1.179 | -9.238 | -3.829 | -14.033 |
| Net Income Ratio
| -0.097 | -0.293 | -0.59 | -0.454 | -0.343 | -0.198 | -0.103 | -0.43 | 0.011 | 0.052 | -1.566 | -0.537 | -1.027 |
| EPS
| -0.17 | -0.91 | -1.98 | -1.37 | -1.18 | -0.65 | -0.24 | -0.78 | 0.019 | 0.06 | -0.61 | -0.25 | -0.93 |
| EPS Diluted
| -0.17 | -0.91 | -1.98 | -1.37 | -1.18 | -0.65 | -0.24 | -0.78 | 0.018 | 0.075 | -0.61 | -0.25 | -0.92 |
| EBITDA
| 5.173 | -10.313 | -27.866 | -17.157 | -9.178 | 0.028 | 0.731 | -11.678 | 3.786 | 4.548 | -6.675 | -7.056 | -3.604 |
| EBITDA Ratio
| 0.06 | -0.126 | -0.348 | -0.246 | -0.139 | 0 | 0.017 | -0.351 | 0.137 | 0.202 | -1.131 | -0.989 | -0.264 |